AIDS Therapies

Genetic Trickery Offers New Way To Target HIV

Published in AIDS Weekly, June 23rd, 1997

Using genetic engineering to fool HIV and disrupt its life cycle, human white blood cells can be made resistant to HIV.

Scientists at the University of Rochester and the University of California at Los Angeles (UCLA) described the novel strategy in the June 6, 1997 issue of the Journal of Biological Chemistry.

"This turns the normal process by which HIV replicates against itself," said Joseph Rosenblatt, the lead investigator and head of Hematology/Oncology at the University of Rochester Cancer Center. "We trick the virus into shutting down its replication process prematurely."

While it's too soon to say whether the work will be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry